Medpace announces Q1 2023 results; press release content not included in filing extract

Medpace Holdings, Inc.

2023-Q1 EPS reported $2.27 revenue$434,074,000

Press release dated April 24, 2023, furnished as Exhibit 99.1 but not provided in the supplied text.
Results cover three months ended March 31, 2023; specific financial figures are unavailable.
Q1 2023 earnings release is materially new but cannot be summarized without the exhibit content.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Medpace Holdings, Inc. reported financial results for the three months ended March 31, 2023.

Period: the three months ended March 31, 2023
Result: reported results

Exact text from the filing

On April 24, 2023, Medpace Holdings, Inc. (the “Company”) issued a press release announcing its financial results for the three months ended March 31, 2023.

View on SEC.gov

Browse all earnings releases →

Medpace Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001668397-23-000029

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.